Archer's hormone health pathway is designed around distinct clinical needs—not one catch-all treatment. Explore men's hormone health and testosterone, male hypogonadism, women's menopausal hormone therapy, and evaluation of adult growth hormone deficiency.
The right pathway depends on symptoms, medical history, appropriate laboratory testing and clinician review. An assessment does not guarantee a prescription.
A broader evaluation of hormone-related concerns in men. This may include symptoms potentially associated with testosterone deficiency, medication and health-history review, fertility goals and investigation of underlying causes.
TRT is prescription testosterone therapy considered for appropriately diagnosed testosterone deficiency. Treatment requires clinical evaluation and appropriate testing, with follow-up and safety monitoring when prescribed.
A separate pathway focused on hormone-related symptoms in women, particularly perimenopause and menopause. A clinician can evaluate symptoms, health history and whether menopausal hormone therapy or another approach may be appropriate.
Evaluation for suspected adult growth hormone deficiency is a specialized endocrine pathway. Diagnosis generally requires more than symptoms alone and may require endocrine testing before growth hormone treatment is considered.
Male hypogonadism is a diagnosis, not a separate branded hormone therapy. It describes testosterone deficiency associated with a problem involving the testes, pituitary/hypothalamic system or another clinically relevant cause. When hypogonadism is confirmed, TRT may be one treatment option depending on the individual.
You do not need to know which medication you need. Choose the pathway that best matches your situation; a licensed clinician determines the appropriate evaluation and next step.
Testosterone & hypogonadism
For men with symptoms or a medical history that may suggest testosterone deficiency.
Perimenopause & menopause
For women experiencing symptoms associated with the menopausal transition or menopause.
Adult growth hormone deficiency
For patients with a clinical reason to investigate possible adult growth hormone deficiency.
Tell us about your symptoms, health history, medications, previous lab results and goals. The clinical review will help determine which pathway—and which next step—is appropriate.
Hormone therapy is prescription medical care. Archer's pathway is structured so that the diagnosis and clinical indication come before a specific medication or hormone regimen.
Share symptoms, health history, medications, fertility considerations, previous diagnoses and available laboratory results.
A licensed clinician determines what testing, additional evaluation or referral is appropriate for the hormone pathway being considered.
If an indication is established, the clinician discusses appropriate treatment options, monitoring and follow-up. A prescription is provided only when medically appropriate.
No. Men's hormone health is the broader clinical category. TRT is one specific prescription treatment that may be considered for appropriately diagnosed testosterone deficiency.
No. Male hypogonadism is a clinical diagnosis. TRT may be used to treat some men with confirmed hypogonadism, depending on the cause, fertility goals, contraindications and clinician assessment.
No. Testosterone and growth hormone are different hormones with different clinical indications and diagnostic pathways. Adult growth hormone deficiency typically requires specialized evaluation and confirmatory testing.
It refers primarily to clinician-guided evaluation of perimenopausal and menopausal symptoms and consideration of menopausal hormone therapy when appropriate. It is a separate pathway from men's TRT.
No. The assessment starts a clinical evaluation. Testing, treatment, referral or another next step is determined by the licensed clinician.
